Loading clinical trials...

Protein S100 Beta as a Predictor of Resuscitation Outcome | Clinical Trials | Clareo Health

UNKNOWNNCT00814814

Protein S100 Beta as a Predictor of Resuscitation Outcome

Management of cardiac arrest is complicated by the lack of a readily available tool identifying individuals who are likely to be successfully resuscitated. S100 beta is a protein that originates in th...

Lead sponsor: Shaare Zedek Medical Center•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment313

Start dateFeb 2008

Last updatedNov 16, 2020

Condition

Cardiopulmonary Arrest Outcome

Locations shown

Shaare Zedek Medical Center

Jerusalem

Hadassah Medical Center

Jerusalem

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 16, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions